← All stocks

DiaMedica Therapeutics Inc.

DMAC Net buying
CIK 0001401040 #3414 in the set updated 18 Sep 2026
Bought (120 mo)
$47.68M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.53M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$3.53M
1 of 1 sales
Net
+$44.15M
+$44.15M against sales at will

By person

16 insiders · 75 transactions
1.7×

Rick Pauls holds only 1.7 times base salary in stock. $1.10M of shares against $645.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Rick Pauls last reported holding, valued at $8.57, the price Common Shares was last bought or sold at on the open market here, on 25 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
STAHLBERG JAN
10% owner
$21.99M (18)
+$21.99M
8,825,742
16.37%
$75.68M
+119.5%
Von Koch Thomas
10% owner
$21.80M (5)
$3.53M (1)
+$18.28M
8,383,577
15.55%
$71.89M
+216.6%
JACINTO RICHARD II
10% owner
$1.40M (1)
+$1.40M
4,958,823
9.20%
$42.52M
+8.8%
Wambeke David J.
Chief Business Officer
$949.20K (3)
+$949.20K
527,114
0.9775%
$4.52M
Giuffre Randall Michael
Director
$560.23K (11)
+$560.23K
479,008
0.8883%
$4.11M
+257.1%
Pilnik Richard D.
Director
$399.49K (9)
+$399.49K
312,995
0.5804%
$2.68M
+1,680%
ALCORN HARRY W JR
SVP, Clinical Operations
$145.05K (7)
+$145.05K
43,981
0.0816%
$377.13K
Burroughs Amy L.
Director
$141.59K (1)
+$141.59K
73,288
0.1359%
$628.44K
Pauls Dietrich John
President & CEO
$112.57K (5)
+$112.57K
128,791
0.2388%
$1.10M
+419.2%
Kellen Scott
CFO & Secretary
$103.01K (6)
+$103.01K
32,290
0.0599%
$276.88K
+1,483%
Semba Charles Pauling
Director
$50.00K (1)
+$50.00K
47,963
0.0889%
$411.28K
Xiao Zhenyu
Director
$13.00K (1)
+$13.00K
1,007,100
1.87%
$8.64M
+0.3%
Parsons James T.
Director
$9.00K (1)
+$9.00K
97,949
0.1816%
$839.90K
+2,592%
Verdoorn Todd A.
Chief Scientific Officer
$4.00K (1)
+$4.00K
2,000
0.0037%
$17.15K
+100.0%
Kuntz Richard
Director
24,210
0.0449%
$207.60K
Gilman Sydney A.
VP, Regulatory Affairs
0
0.0000%
$0.00
Insider
Date
Role
Action
Shares
Price
Amount
STAHLBERG JAN
25 Nov 2025
10% owner
Buy indirect
73,099
$8.57
$626.82K
STAHLBERG JAN
24 Nov 2025
10% owner
Buy indirect
40,253
$7.89
$317.72K
STAHLBERG JAN
21 Nov 2025
10% owner
Buy indirect
208,872
$7.41
$1.55M
STAHLBERG JAN
20 Nov 2025
10% owner
Buy indirect
128,426
$7.41
$951.21K
STAHLBERG JAN
19 Nov 2025
10% owner
Buy indirect
240,352
$7.21
$1.73M
STAHLBERG JAN
18 Nov 2025
10% owner
Buy indirect
182,882
$6.75
$1.23M
STAHLBERG JAN
17 Nov 2025
10% owner
Buy indirect
187,393
$6.52
$1.22M
STAHLBERG JAN
27 Aug 2025
10% owner
Buy indirect
50,772
$6.00
$304.63K
STAHLBERG JAN
26 Aug 2025
10% owner
Buy indirect
59,648
$6.00
$357.89K
STAHLBERG JAN
25 Aug 2025
10% owner
Buy indirect
338,265
$6.00
$2.03M
STAHLBERG JAN
22 Aug 2025
10% owner
Buy indirect
59,788
$5.96
$356.58K
STAHLBERG JAN
21 Aug 2025
10% owner
Buy indirect
48,172
$5.96
$287.03K
STAHLBERG JAN
20 Aug 2025
10% owner
Buy indirect
71,107
$5.86
$416.50K
STAHLBERG JAN
15 Aug 2025
10% owner
Buy indirect
8,233
$6.00
$49.40K
STAHLBERG JAN
14 Aug 2025
10% owner
Buy indirect
70,414
$5.99
$421.92K
STAHLBERG JAN
13 Aug 2025
10% owner
Buy indirect
293,601
$5.91
$1.73M
JACINTO RICHARD II
23 Jul 2025
10% owner
Buy indirect
400,000
$3.50
$1.40M
Von Koch Thomas
23 Jul 2025
10% owner
Buy indirect
2,857,142
$3.50
$10.00M
STAHLBERG JAN
23 Jul 2025
10% owner
Buy indirect
1,542,857
$3.50
$5.40M
STAHLBERG JAN
28 Jun 2024
10% owner
Buy indirect
1,200,000
$2.50
$3.00M
Von Koch Thomas
28 Jun 2024
10% owner
Buy indirect
1,200,000
$2.50
$3.00M
Wambeke David J.
16 Nov 2023
Chief Business Officer
Buy
20,000
$2.46
$49.20K
Pilnik Richard D.
23 Jun 2023
Director
Buy
38,363
$3.91
$150.00K
Wambeke David J.
23 Jun 2023
Chief Business Officer
Buy
38,364
$3.91
$150.00K
Kellen Scott
23 Jun 2023
CFO and Secretary
Buy
10,000
$3.91
$39.10K
Semba Charles Pauling
23 Jun 2023
Director
Buy
12,787
$3.91
$50.00K
Pauls Dietrich John
23 Jun 2023
President and CEO
Buy
12,787
$3.91
$50.00K
Giuffre Randall Michael
23 Jun 2023
Director
Buy
65,000
$3.91
$254.15K
Von Koch Thomas
23 Jun 2023
10% owner
Buy indirect
1,470,588
$3.40
$5.00M
Wambeke David J.
10 Apr 2023
Chief Business Officer
Buy
468,750
$1.60
$750.00K
Giuffre Randall Michael
9 Dec 2022
Director
Buy
37,079
$1.43
$53.02K
Giuffre Randall Michael
8 Dec 2022
Director
Buy
20,000
$1.40
$28.00K
Giuffre Randall Michael
7 Dec 2022
Director
Buy
22,574
$1.40
$31.60K
Giuffre Randall Michael
6 Dec 2022
Director
Buy
2,300
$1.35
$3.11K
Pilnik Richard D.
5 Dec 2022
Director
Buy
35,000
$1.39
$48.49K
Von Koch Thomas
2 Dec 2022
10% owner
Buy indirect
2,855,847
$1.24
$3.53M
Giuffre Randall Michael
1 Dec 2022
Director
Buy
46,133
$1.20
$55.36K
Giuffre Randall Michael
1 Dec 2022
Director
Buy
819
$1.19
$974.61
Giuffre Randall Michael
30 Nov 2022
Director
Buy
2,970
$1.19
$3.53K
Giuffre Randall Michael
29 Nov 2022
Director
Buy
18,125
$1.19
$21.57K
Pauls Dietrich John
16 Nov 2022
President and CEO
Buy
20,000
$1.21
$24.20K
Von Koch Thomas
8 Jul 2022
10% owner
Buy indirect
207,974
$1.33
$275.90K
ALCORN HARRY W JR
15 Sep 2021
SVP, Clinical Operations
Buy
15,000
$3.80
$56.96K
Kellen Scott
16 Aug 2021
CFO and Secretary
Buy
10,000
$3.15
$31.46K
Pauls Dietrich John
16 Aug 2021
President and CEO
Buy
5,000
$3.14
$15.70K
ALCORN HARRY W JR
16 Aug 2021
Senior VP, Clinical Operations
Buy indirect
399
$3.07
$1.22K
ALCORN HARRY W JR
16 Aug 2021
Senior VP, Clinical Operations
Buy
322
$3.06
$984.93
ALCORN HARRY W JR
16 Aug 2021
Senior VP, Clinical Operations
Buy
20,000
$3.09
$61.84K
Pilnik Richard D.
16 Aug 2021
Director
Buy
12,500
$3.28
$41.03K
Pilnik Richard D.
16 Aug 2021
Director
Buy
2,500
$3.21
$8.03K
Burroughs Amy L.
16 Aug 2021
Director
Buy
44,950
$3.15
$141.59K
Pilnik Richard D.
4 Dec 2020
Director
Buy
5,000
$5.24
$26.20K
Pilnik Richard D.
4 Dec 2020
Director
Buy
5,000
$5.50
$27.50K
Giuffre Randall Michael
20 Nov 2020
Director
Buy
15,000
$4.26
$63.91K
Kellen Scott
9 Nov 2020
CFO and Secretary
Buy
2,000
$4.19
$8.39K
Kellen Scott
19 Aug 2019
CFO and Secretary
Buy
3,000
$2.43
$7.29K
Pauls Dietrich John
16 Aug 2019
President and CEO
Buy
1,000
$2.68
$2.68K
ALCORN HARRY W JR
16 Aug 2019
Chief Medical Officer
Buy
7,260
$2.67
$19.37K
Pilnik Richard D.
16 Aug 2019
Director
Buy
7,840
$2.56
$20.04K
Pilnik Richard D.
31 May 2019
Director
Buy
19,000
$2.80
$53.20K
Kellen Scott
24 May 2019
CFO and Secretary
Buy
4,000
$2.94
$11.77K
ALCORN HARRY W JR
27 Mar 2019
Chief Medical Officer
Buy
150
$4.46
$668.39
ALCORN HARRY W JR
11 Dec 2018
Chief Medical Officer
Buy
1,000
$4.00
$4.00K
Giuffre Randall Michael
11 Dec 2018
Director
Buy
11,250
$4.00
$45.00K
Kellen Scott
11 Dec 2018
CFO and Secretary
Buy
1,250
$4.00
$5.00K
Parsons James T.
11 Dec 2018
Director
Buy
2,250
$4.00
$9.00K
Pauls Dietrich John
11 Dec 2018
President and CEO
Buy
5,000
$4.00
$20.00K
Pilnik Richard D.
11 Dec 2018
Director
Buy
6,250
$4.00
$25.00K
Verdoorn Todd A.
11 Dec 2018
Chief Scientific Officer
Buy
1,000
$4.00
$4.00K
Xiao Zhenyu
11 Dec 2018
Director
Buy
3,250
$4.00
$13.00K

What was left out

Form 4 filings counted 153
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 537,701
Sales filed before the plan box existed 1
History held since 11 Dec 2018